CEO Executive AssistantCommercial operations represent the revenue engine of a pharmaceutical company. From pre-launch planning through mature product management, commercial functions require deep operational expertise and intensive day-to-day management. The pharma CEO who tries to personally direct commercial operations is both interfering with expert commercial leadership and neglecting the strategic priorities only they can address.
This guide provides a practical delegation framework for pharma CEOs managing commercial responsibilities.
What the Pharma CEO Should Own Commercially
The CEO’s commercial responsibilities are strategic, not operational:
Commercial strategy approval. Product positioning, target patient population, channel strategy, and pricing philosophy require CEO-level strategic approval because they define the revenue trajectory and organizational priorities.
Key customer relationships at the C-suite level. Relationships with major pharmacy chains, hospital system executives, PBM leadership, and key payer executives may warrant CEO engagement at strategic moments.
Investor communications about commercial performance. Revenue guidance, product launch updates, and commercial performance narratives for investors and analysts are CEO-level communications.
Launch investment decisions. Major resource allocation decisions about launch preparation, sales force sizing, and marketing investment require CEO approval.
Commercial leadership accountability. The CEO holds the Chief Commercial Officer, VP of Marketing, and VP of Sales accountable for commercial performance through direct management relationships.
Commercial Delegation Framework
To the Chief Commercial Officer
The CCO owns the full commercial operation. Key delegations include:
Sales force strategy and management. Sales force design, territory assignments, incentive compensation design, performance management, and field leadership are CCO and VP of Sales responsibilities.
Marketing operations. Brand strategy execution, promotional materials development, digital marketing, congress presence, and marketing campaign management are marketing department functions.
Payer and market access strategy execution. While market access strategy requires CEO alignment, tactical implementation with payers, PBMs, and formulary management is the CCO’s responsibility.
Launch planning and execution. Pre-launch preparation, launch readiness reviews, early launch tracking, and launch adjustment decisions are commercial leadership functions.
Commercial analytics. Market research, competitive intelligence, sales performance analytics, and commercial forecasting are commercial analytics team responsibilities.
Speaker bureau and HCP engagement programs. Managing physician speaker programs, advisory boards, and HCP engagement activities within compliance guidelines is a medical affairs and commercial team function.
To the VP of Marketing
Brand planning. Annual brand plans, tactical plans, and marketing budget management are marketing leadership responsibilities.
Agency management. Managing advertising, PR, and digital marketing agency relationships is a marketing operations function.
Congress and medical meeting strategy. Planning organizational presence at key medical conferences is a marketing and medical affairs function.
Digital marketing and omnichannel programs. Digital platforms, digital advertising, and customer engagement technology are marketing responsibilities.
To the VP of Sales
Sales force management. Day-to-day sales force management, field coaching, regional director oversight, and performance accountability are VP of Sales responsibilities.
Sales operations. CRM management, call planning systems, incentive compensation administration, and sales reporting are sales operations functions.
Managed care pull-through. Working with the managed care team to translate payer wins into field execution is a sales operations responsibility.
To the Market Access and Pricing Team
Formulary negotiations. Negotiations with PBMs and payers on formulary positioning and rebate structures are market access team responsibilities.
Patient access programs. Co-pay assistance, patient support programs, and hub services are managed access functions.
Pricing analytics. Ongoing pricing analysis, competitive pricing monitoring, and pricing scenario modeling are market access and finance functions.
Building Commercial Delegation Infrastructure
Monthly Commercial Performance Review
A structured monthly commercial review covers key commercial metrics: prescription trends, market share, managed care formulary status, sales performance versus target, and competitive activity. The CEO attends but reviews rather than manages.
Commercial Dashboard for CEO
The CCO provides a one-page CEO commercial dashboard covering:
- Net revenue versus budget and prior period
- Prescription volume and market share trends
- Key payer coverage status
- Sales force productivity metrics
- Launch milestone status for recently launched products
Commercial Governance Calendar
A quarterly commercial planning calendar maps brand planning cycles, annual review timelines, and key commercial milestone reviews. The CEO participates in major milestone reviews; routine commercial meetings proceed without CEO attendance.
Compliance-Driven Delegation Considerations
Pharmaceutical commercial operations operate in a heavily regulated promotional environment. The CEO must ensure that:
- The legal and compliance function has adequate resources and independence to oversee commercial promotional activities
- Medical, legal, and regulatory review processes are properly resourced
- Compliance training and monitoring programs are funded and functioning
- The CEO’s own communications about the company’s products comply with relevant disclosure standards
These are CEO accountability responsibilities, but their operational execution belongs with the compliance and legal teams.
For pharma CEOs building broader executive delegation systems, what pharmaceutical biotech CEOs delegate to their chief of staff provides complementary frameworks.
Commercial delegation at the pharmaceutical company level is closely related to the broader CEO delegation principles in CEO task prioritization.
Conclusion
Pharmaceutical commercial operations require expert leadership and disciplined execution. The pharma CEO who invests in strong commercial talent and establishes clear accountability structures can focus on strategy, investor relations, and pipeline decisions while confident that commercial execution is in capable hands.
Trust the commercial team. Review performance regularly. Engage strategically. The revenue will follow.
For pharmaceutical commercial strategy insights, visit McKinsey.com/industries/life-sciences.
Related Reading
For further context, explore Delegation Guide for Affordable Housing Nonprofit CEOs and Delegation Guide for Automotive CEO: Brand Management.